Joshua A. Owens

Joshua A. Owens

Auto-generated profile, based on publicly available information

Joshua A. Owens

Department of Pediatrics, Emory University School of Medicine, Atlanta, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Immunity
Verified
Journal Article
Open access
ATAbdul Malik Tyagi
Abdul Malik Tyagi
MYMingcan Yu
Mingcan Yu
TDTrevor M. Darby
Trevor M. Darby
CVChiara Vaccaro
Chiara Vaccaro
JLJau-Yi Li
Jau-Yi Li
RPRoberto Pacifici
Roberto Pacifici
Nutritional supplementation with probiotics can prevent pathologic bone loss. Here we examined the impact of supplementation with Lactobacillus rhamnosus GG (LGG) on bone homeostasis in eugonadic young mice. Micro-computed tomography revealed that LGG increased trabecular bone volume in mice, which was due to increased bone formation. Butyrate produced in the gut following LGG ingestion, or butyrate fed directly to germ-free mice, induced the expansion of intestinal and bone marrow (BM) regulatory T (Treg) cells. Interaction of BM CD8+ T cells with Treg cells resulted in increased secretion of Wnt10b, a bone anabolic Wnt ligand. Mechanistically, Treg cells promoted the assembly of a NFAT1-SMAD3 transcription complex in CD8+ cells, which drove expression of Wnt10b. Reducing Treg cell numbers, or reconstitution of TCRβ-/- mice with CD8+ T cells from Wnt10b-/- mice, prevented butyrate-induced bone formation and bone mass acquisition. Thus, butyrate concentrations regulate bone anabolism via Treg cell-mediated regulation of CD8+ T cell Wnt10b production.

1 August 2020 in Gastroenterology
Verified
Journal Article
Closed access
CNCrystal Naudin
Crystal Naudin
KMKristal Maner-Smith
Kristal Maner-Smith
JOJoshua A. Owens
Joshua A. Owens
GWGrace M. Wynn
Grace M. Wynn
BRBrian S. Robinson
Brian S. Robinson
RJRheinallt M Jones
Rheinallt M Jones

20 December 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
KLKen H. Liu
Ken H. Liu
JOJoshua A. Owens
Joshua A. Owens
BSBejan Saeedi
Bejan Saeedi
CCCatherine E. Cohen
Catherine E. Cohen
MBMoriah P. Bellissimo
Moriah P. Bellissimo
DJDean P. Jones
Dean P. Jones

1 February 2019 in iScience
Verified
Journal Article
Open access
TDTrevor M. Darby
Trevor M. Darby
JOJoshua A. Owens
Joshua A. Owens
BSBejan J. Saeedi
Bejan J. Saeedi
LLLiping Luo
Liping Luo
JMJason D. Matthews
Jason D. Matthews
RJRheinallt M Jones
Rheinallt M Jones
The use of beneficial bacteria to promote health is widely practiced. However, experimental evidence corroborating the efficacy of bacteria promoted with such claims remains limited. We address this gap by identifying a beneficial bacterium that protects against tissue damage and injury-induced inflammation in the gut. We first employed the Drosophila animal model to screen for the capacity of candidate beneficial bacteria to protect the fly gut against injury. From this screen, we identified Lactococcus lactis subsp. cremoris as a bacterium that elicited potent cytoprotective activity. Then, in a murine model, we demonstrated that the same strain confers powerful cytoprotective influences against radiological damage, as well as anti-inflammatory activity in a gut colitis model. In summary, we demonstrate the positive salutary effects of a beneficial bacterium, namely, L. lactis subsp. cremoris on intestinal tissue and propose the use of this strain as a therapeutic to promote intestinal health.

4 May 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
BRBrian S. Robinson
Brian S. Robinson
BSBejan Saeedi
Bejan Saeedi
CAConnie M. Arthur
Connie M. Arthur
JOJosh Owens
Josh Owens
CNCrystal Naudin
Crystal Naudin
SSSean R. Stowell
Sean R. Stowell

1 January 2020 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
AWAlexandra A. Wolfarth
Alexandra A. Wolfarth
XLXu Liu
Xu Liu
TDTrevor M. Darby
Trevor M. Darby
DBDarra J. Boyer
Darra J. Boyer
JSJocelyn B. Spizman
Jocelyn B. Spizman
ANAndrew S. Neish
Andrew S. Neish
The intestinal epithelium must be resilient to physiochemical stress in order to uphold the physiological barrier separating the systemic compartment from the microbial and antigenic components of the gut lumen. Identifying proteins that mediate protection and enhancing their expression is therefore a clear approach to promote intestinal health. We previously reported that oral ingestion of the probiotic Lactobacillus rhamnosus GG (LGG) not only induced the expression of several recognized cytoprotective factors in the murine colon, but also many genes with no previously described function, including the gene encoding proline rich acidic protein-1 (PRAP1). PRAP1 is a protein highly expressed in the epithelium of the gastrointestinal tract and we sought to define its function in this tissue. Purified preparations of recombinant PRAP1 were analyzed biochemically and PRAP1 antisera were used to visualize localization in tissues. Prap1-/- mice were characterized at baseline and challenged with total body irradiation and lastly, enteroids were generated to recapitulate the irradiation challenge ex vivo. PRAP1 is a 17 kDa intrinsically disordered protein with no recognizable sequence homology. PRAP1 expression levels were high in the epithelia of the small intestine. While Prap1-/- mice presented only mild phenotypes at baseline, they were highly susceptible to intestinal injury upon challenge. After irradiation the Prap1-/- mice exhibited dramatically higher mortality rates with a significant increase in apoptosis and p21 expression in the small intestinal epithelium. PRAP1 is an intrinsically disordered protein highly expressed by the gastrointestinal epithelium and functions at exposed surfaces to protect the barrier from oxidative insult.